The United States spends nearly $1 out of every $5 of its economy on healthcare, with total expenditures reaching $5.3 trillion in 2024. Yet despite record spending, the nation continues to face a healthcare affordability crisis. Patients are paying more, providers are facing higher operating costs, and employers continue to absorb rising benefit costs.
Looking ahead, the outlook is equally concerning. Commercial healthcare costs are projected to increase by another 9% in 2027, signalling a potential affordability crisis. To understand why healthcare spending continues to rise, let’s examine the factors driving costs across the healthcare system.
5 Trends Fuelling Rising Healthcare Costs in the U.S.
The shifting economics of U.S. healthcare are creating financial pressures throughout the healthcare ecosystem. Patients, providers, payers, and government programs are all feeling the impact. Here are five key trends driving healthcare costs higher.
1. Insurance Premiums
Recent policy and regulatory changes are reshaping the ACA marketplace and intensifying affordability challenges. The expiration of enhanced premium tax credits, the enactment of the One Big Beautiful Bill Act (OBBBA), and stricter eligibility requirements under the Marketplace Integrity and Affordability Rule have contributed to proposed premium increases averaging nearly 18% for 2026, the largest increase in almost a decade.
Higher premiums are already shaping consumer behaviour. ACA marketplace enrolment declined by more than 1 million in 2026. Among those who remained enrolled, many shifted to lower-premium, higher-deductible plans to manage costs. While this “plan buydown” trend helps maintain coverage, it increases out-of-pocket expenses, leaving many financially vulnerable. For providers, higher deductibles often translate into greater patient collection challenges and higher bad debt.
Furthermore, as some insurers scale back or exit certain ACA marketplaces due to rising medical costs and enrolment uncertainty, reduced competition and limited plan choices make it increasingly difficult for consumers to find affordable coverage.
2. Prescription Drugs
Prescription drug spending remains one of the fastest-growing components of healthcare expenditures. U.S. gross drug spending is projected to rise by about approximately 8% annually through 2029, approaching $1 trillion by the end of the decade. Much of this growth is driven by surging demand for GLP-1 medications, specialty drugs, biologics, and gene therapies.
The rapid adoption of GLP-1 medications has created new affordability challenges. Employers are reassessing coverage policies, while health plans are factoring higher pharmaceutical costs into their pricing strategies. Some insurers have cited rising specialty drug costs and uncertainty about future pharmaceutical pricing as reasons for premium increases in 2026.
For patients, higher drug costs can lead to greater out-of-pocket costs and medication adherence challenges. Providers face additional administrative burdens from prior authorizations and coverage appeals. Meanwhile, payers continue to balance patient access with cost-containment efforts.
In response, policymakers are pursuing affordability initiatives, including the TrumpRx website, the Consolidated Appropriations Act of 2026, and Medicare drug price negotiations. However, whether these measures will be sufficient to offset the growing demand for specialty medications remains to be seen.
3. Artificial Intelligence Implementation
AI has matured from an experimental novelty into a core operational anchor. Recent data indicate that 71% of U.S. hospitals use AI tools to reduce administrative burdens and eliminate systemic friction.
As the U.S. population ages and the prevalence of chronic conditions and comorbidities rises, providers are caring for more medically complex patients. AI-powered ambient scribes and coding assistants help organizations accurately document patient complexity and capture full reimbursement for high-acuity services.
As providers leverage AI to optimize revenue capture, payers are responding with AI-powered payment integrity and claims review solutions to identify coding anomalies and monitor shifts in case severity. The result is an ongoing, technology-driven effort by providers and payers to balance accurate reimbursement with cost containment.
4. Provider Consolidation
Market consolidation has improved care coordination and operational efficiency, but it has also concentrated market power in the hands of a few dominant health systems. This shrinking competitive landscape has reduced consumer choice and driven up healthcare costs by giving large organizations greater leverage to negotiate higher reimbursement rates.
5. Medicaid Cuts
The Medicaid overhauls enacted under the One Big Beautiful Bill Act (OBBBA) are projected to leave 7.8 million Americans without coverage over the next decade.
Beyond individual coverage losses, states face additional financial and administrative burdens as they implement new compliance requirements amid reduced federal support and funding restrictions.
Providers, particularly safety-net and rural hospitals, may see higher levels of uncompensated care as more patients lose coverage. Combined with ongoing reimbursement pressures, these changes could create significant financial challenges for healthcare organizations serving vulnerable populations.
Healthcare costs are driven by intersecting forces, including inflation, policy overhauls, provider consolidation, AI, and advances in medical science. The challenge ahead is to balance innovation, access, and affordability without further pushing quality care out of reach for patients who need it most.